Yoji Hirai

20PUBLICATIONS
55CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 19, 2024
The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis.

Yoshihiro Matsuda, Tomoko Miyake, Hironobu Toda

|Jun 14, 2024
Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.

Yoji Hirai, Jun Sakurai, Shiho Yoshida

|May 30, 2023
Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.

Yoji Hirai, Hideo Asada, Toshihisa Hamada

|Oct 05, 2022
Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patients.

Jun Yamagami, Yuichi Kurihara, Takeru Funakoshi

|Oct 18, 2021
Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance.

Toshihisa Hamada, Akimichi Morita, Hiraku Suga

|Jul 15, 2021
Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies.

Yuki Nakagawa, Toshihisa Hamada, Takahide Takahashi

Pageof 4

Frequent Collaborators

13 joint publications

Shin Morizane

10 joint publications

Yoshio Kawakami

8 joint publications

Tomoko Miyake

4 joint publications

Toshihisa Hamada